陈海燕,左金霞,甄宏博,钟雯,沈冰,韩倩倩
CHEN Haiyan,ZUO Jinxia,ZHEN Hongbo,ZHONG Wen,SHEN Bing,HAN Qianqian

• 1:北京市第六医院眼科

摘要(Abstract)：

目的:分析眼底激光光凝治疗糖尿病性黄斑水肿(DME)的临床疗效。方法:66例DME患者102眼行眼底激光光凝治疗,比较治疗前、治疗后1、3、6及12个月时患者的最佳矫正视力(BCVA)以及眼底荧光血管造影检查(FFA)黄斑水肿的消退情况。结果:眼底激光光凝治疗后,术后1、3、6及12月BCVA检测视力提高比例逐渐增高;与治疗前比较,治疗后12个月DME患者视力≥0.5的人数较多,差异有统计学意义(Z=3.52,P=0.004);FFA检查示,DME完全消退47眼(46.08%),好转38眼(37.26%),治疗无效12眼(11.76%),黄斑水肿加重5眼(4.90%);治疗中无并发症发生。结论:眼底激光光凝治疗DME疗效稳定、安全。
Objective: To investigate the therapeutic efficacy of retinal laser photocoagulation for the treatment of diabetic macular edema( DME). Methods: 102 eyes of 66 cases in DME patients were performed with the treatment of retinal laser photocoagulation. The best corrected visual acuity( BCVA),colour fundus photography and fundus fluorescein angiography( FFA) were performed before the treatment and during follow-up period. Results: After the treatment of retinal laser photocoagulation,final BCVA was improved in 44 eyes( 43. 14%),stable in 24 eyes( 23. 53%),decreased in 34 eyes( 33. 33%),the difference was statistically significant compared with former treatment( P = 0. 004).Meanwhile, DME completely eliminated in 47eyes( 46. 08%), partly eliminated in 38 eyes( 37. 26%),unchanged in 12eyes( 11. 76%),and worsened in 5 eyes( 4. 90%). Conclusion: The treatment of retinal laser photocoagulation is safe and effective for the patients of diabetic macular edema.

关键词(KeyWords)： 糖尿病;黄斑水肿;视力;激光光凝;眼底荧光血管造影;疗效
diabetes;macular edema;vision;laser photocoagulation;fundus fluoresce in angiography;clinical effect

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 陈海燕,左金霞,甄宏博,钟雯,沈冰,韩倩倩
CHEN Haiyan,ZUO Jinxia,ZHEN Hongbo,ZHONG Wen,SHEN Bing,HAN Qianqian

DOI: 10.19367/j.cnki.1000-2707.2017.06.024

参考文献(References)：

• [1]田军.不同方法治疗糖尿病黄斑水肿的对比观察[J].中华眼外伤职业眼病杂志,2015(7):534-538.
• [2]孙心铨.糖尿病性黄斑水肿激光治疗临床分析[J].眼科,2008(17):242-245.
• [3]黎晓新,王宁利,陈有信,等.我糖尿病视网膜病变临床诊疗指南(2014年)[J].中华眼科杂志,2014(11):851-886.
• [4]张承芬,张惠蓉.糖尿病的眼部并发症及治疗[M].北京:人民卫生出版社,2003:57-59.
• [5]齐慧君,黎晓新.糖尿病性黄斑水肿的激光治疗[J].眼科,2005(14):234-236.
• [6]Haritoglou C,Kook D,Neubauer A,et al.Intravitreal bevacizumab(Avastin)therapy for persistent diffuse diabetic macular edema[J].Retina,2006(9):999-1005.
• [7]Soheilian M,Ramezani A,Bijianzadeh B,et al.Intravitreal bevacizumab(avastin)injection alone or combinedwith triamcinolone versusmacular photocoagulation as primary treatment of diabetic macular edema[J].Rtina,2007(9):1187-1195.
• [8]Liu XD,Zhou XD,Wang Z,et al.Comparision of intravitreal bevacizumab with macular photocoagulation for treatment of diabeticmacular edema:a systemic review and Meta-analysis[J].Int J Opthalmol,2014(6):1048-1055.
• [9]Yan P,Qian C,Wang W,et al.Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation[J].Ther Clin Risk Manag,2016(12):527-533.

文章评论(Comment)：